After 20 percent of the agency’s work force was cut, federal health officials have decided to bring back some experts and review firings to fill gaps in critical roles.
Category: Generic Brands and Products
-
Trump’s Tariff Threat for Drug imports Poses Big Political Risks
Levies on Americans’ daily prescriptions and other medicines could raise costs, spur rationing and lead to shortages of critical drugs.
-
Trump’s Next Tariffs Target Could be Foreign-Made Pharmaceuticals
President Trump wants to bring pharmaceutical manufacturing back to the United States. Experts warn that tariffs could result in shortages and higher prices for generic drugs.
-
FDA Layoffs Could Raise Drug Costs and Erode Food Safety
Trump cutbacks were supposedly aimed at administrators. But scientists in food and drug-testing labs and policy experts who advance generic drug approvals were also dismissed.
-
Gilead Agrees to Allow Generic Version of Groundbreaking H.I.V. Shot in Poor Countries
Many middle-income countries are left out of the deal, widening a gulf in access to critical medicines.
-
What to Do if You’re Overpaying for Prescriptions
Here’s what to know about your pharmacy benefit manager and how to find out if you are being overcharged for medications.
-
Walmart Introduces a New Store Brand for ‘Quality Food’
The Better Goods store brand will carry plant-based, gluten-free and higher-end food and could help the retailer attract more affluent shoppers.
-
US Agencies Start Inquiry Into Generic Drug Shortages
The F.T.C. and H.H.S. are examining the tactics of group purchasing organizations that generic industry executives say have led to scarce supplies of treatments like chemotherapy.
-
Behind the Shortage Keeping Cancer Patients From Chemo
Key drugs have been in scarce supply, revealing a deep crisis in the generic drug industry.
-
Possible Ways to Ease Drug Shortages
Lawmakers, U.S. officials and industry experts have offered measures to try to shore up the generic drug market.
-
Those Doritos Too Expensive? More Stores Offer Their Own Alternatives.
Retailers are expanding their own private-label food and beverage offerings, attracting customers looking for less expensive options.
-
Common Patenting Tactic by Drug Companies May Be Illegal, F.T.C. Says
Experts say the exploitation of a loophole in the patent system has contributed to high prices for inhalers.